Conventional transcatheter aortic valve replacement (TAVR) relies on fluoroscopic and contrast agents. However, in high-risk patients, exposure to ionizing radiation and contrast agents is contraindicated and undesirable. Echocardiography guidance TAVR can offer a feasible and safer strategy for TAVR.
Study Type
OBSERVATIONAL
Enrollment
20
Fuwai Hospital
Beijing, China
RECRUITINGValve Academic Research Consortium-3 (VARC-3)
VARC3 include but not limited to Mortality (all-cause and cardiovascular) Stroke and transient ischemic attack (TIA) Acute kidney injury Conduction disturbances and permanent pacemaker implantation Bleeding (updated using BARC criteria) Myocardial infarction Vascular access complications Endocarditis
Time frame: 30-day after surgery
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.